The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary - Cancer rates are rising everywhere ...

Lung cancer remains the leading cause of cancer mortality worldwide. Immunotherapy has recently emerged as a promising therapeutic strategy both for ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...

Lung cancer is the leading cause of cancer-related mortality globally. Although low-dose computed tomography (LDCT) has shown ...

Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...

Calidi Biotherapeutics Inc. has spent over 10 years developing a groundbreaking platform for the systemic delivery of genetic medicines that can precisely target tumors. One of the company's core ...

Researchers in China say the bacteria in your gut—and beyond—may play a role in your chance of developing one of the leading ...

AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...